Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raloxifene (raloxifene)
  • Tibolone (tibolone)

Snippet

Sponsor: Organon and Co | Conditions: Osteopenia | Phase 4 | Status: COMPLETED